1. All Products
  2. D - Drugs
  3. CEFTRIAXONE sodium, eq. 1g base, powder, vial
Public Pricelist

CEFTRIAXONE sodium, eq. 1g base, powder, vial

https://medicalguidelines.msf.org/en/node/767
https://unicat.msf.org/cat/product/11650
STD DINJCEFT1V-

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
6.2.2 - Watch group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01DD04
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

CEFTRIAXONE

Therapeutic Action

Third-generation cephalosporin antibacterial

Indications

Severe bacterial infections (meningitis, pneumonia, typhoid fever, shigellosis, leptospirosis, tick-borne relapsing fevers, pyelonephritis, neurosyphilis, etc.)

Cervicitis, urethritis and conjunctivitis due to Neisseria gonorrhoeae, chancroid

Instructions for use

Reconstitute the powder vial with water for injection.

The reconstituted solution must be given as slow IV injection or infusion in 0.9% NaCl or 5% dextrose.

The 250 mg dosage is intended for paediatric use.

Precautions for Use

Do not mix ceftriaxone with calcium-containing solutions (such as ringer lactate): risk of particulate formation.

Do not confuse with ceftriaxone + lidocaine administered by IM route only.

Storage

  • Below 25°C - Protect from sunlight
  • After reconstitution, use the solution immediately.